Swerdlow AJ - Search Results

1

Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.

Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV. Swerdlow AJ, et al. J Clin Oncol. 2012 Aug 1;30(22):2745-52. doi: 10.1200/JCO.2011.38.8835. Epub 2012 Jun 25. J Clin Oncol. 2012. PMID: 22734026

2

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

Swerdlow AJ, Douglas AJ, Hudson GV, Hudson BV, Bennett MH, MacLennan KA. Swerdlow AJ, et al. BMJ. 1992 May 2;304(6835):1137-43. doi: 10.1136/bmj.304.6835.1137. BMJ. 1992. PMID: 1392790 Free PMC article.

3

Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution.

dos Santos Silva I, Swerdlow AJ. dos Santos Silva I, et al. Among authors: swerdlow aj. Br J Cancer. 1993 Feb;67(2):330-40. doi: 10.1038/bjc.1993.61. Br J Cancer. 1993. PMID: 8431362 Free PMC article.

4

Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys.

Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ. Peto J, et al. Among authors: swerdlow aj. Int J Cancer. 1996 Jan 26;65(3):275-83. doi: 10.1002/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8575845

5

Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys.

Easton DF, Matthews FE, Ford D, Swerdlow AJ, Peto J. Easton DF, et al. Among authors: swerdlow aj. Int J Cancer. 1996 Jan 26;65(3):284-94. doi: 10.1002/(SICI)1097-0215(19960126)65:3<284::AID-IJC2>3.0.CO;2-W. Int J Cancer. 1996. PMID: 8575846

6

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.

Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ. Swerdlow AJ, et al. Br J Cancer. 1997;75(1):116-23. doi: 10.1038/bjc.1997.19. Br J Cancer. 1997. PMID: 9000608 Free PMC article.

7

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC. Swerdlow AJ, et al. J Clin Oncol. 2000 Feb;18(3):498-509. doi: 10.1200/JCO.2000.18.3.498. J Clin Oncol. 2000. PMID: 10653865

8

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM. Swerdlow AJ, et al. J Clin Endocrinol Metab. 2000 Dec;85(12):4444-9. doi: 10.1210/jcem.85.12.7044. J Clin Endocrinol Metab. 2000. PMID: 11134091 Clinical Trial.

9

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.

Swerdlow AJ, Schoemaker MJ, Allerton R, Horwich A, Barber JA, Cunningham D, Lister TA, Rohatiner AZ, Vaughan Hudson G, Williams MV, Linch DC. Swerdlow AJ, et al. J Clin Oncol. 2001 Mar 15;19(6):1610-8. doi: 10.1200/JCO.2001.19.6.1610. J Clin Oncol. 2001. PMID: 11250989

10

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study.

Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Swerdlow AJ, et al. Lancet. 2002 Jul 27;360(9329):273-7. doi: 10.1016/s0140-6736(02)09519-3. Lancet. 2002. PMID: 12147369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters